MBX Biosciences
Carmel · Founded 2019
About MBX Biosciences
MBX Biosciences is a biotechnology company that develops therapies to treat rare endocrine diseases where there is inadequate treatment available. It focuses on the discovery, development, and commercialization of first-in-class endocrine therapeutics.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1M – $10M
- Total funding: $238.4M
- Funding stage: IPO
- Last round: Series C (Aug 2024)
- Ticker: nasdaq:MBX
- Website: https://www.mbxbio.com
- Phone: +1 (317) 659-0200
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mbx-biosciences-123606 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.